Could a common supplement protect eyesight after retinal detachment?

NCT ID NCT06587945

Recruiting now Disease control Sponsor: Center for Eye Research Australia Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether taking nicotinamide riboside (a vitamin B3-like supplement) can help preserve vision in people with a detached retina affecting the macula (central vision). Participants take the supplement or a placebo daily for 20 weeks, starting at diagnosis. The goal is to see if it helps retinal cells survive and recover after standard surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: nicotinamide riboside (a dietary supplement)
What this could lead to: If it works, this could offer a simple, safe supplement to help preserve vision after retinal detachment surgery.
What could go wrong: This is a small, early-phase trial. The supplement may not improve vision outcomes, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RETINAL DETACHMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

retinal detachment

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RETINAL DETACHMENT

Contacts and locations

Locations

Centre for Eye Research Australia
RECRUITING

East Melbourne, Victoria, 3002, Australia
Cerulea
RECRUITING

East Melbourne, Victoria, 3002, Australia
Dr David Fabinyi
RECRUITING

Geelong, Victoria, 3220, Australia
Dr David Sousa
RECRUITING

Geelong, Victoria, 3220, Australia
The Royal Victorian Eye and Ear Hospital
RECRUITING

East Melbourne, Victoria, 3002, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.